Stand Up To Cancer is supporting a translational research team to explore how chimeric antigen receptor T-cell therapy, which has been applied in blood cancers, can be applied to pancreatic cancer, the American Association for Cancer Research, SU2C’s Scientific Partner, announced.
As NCI employees and others at HHS were receiving notices of termination, national cancer organizations called on Congress “to restore stability to NIH.”
